Anhui Anke Biotechnology (Group) Balance Sheet Health
Financial Health criteria checks 6/6
Anhui Anke Biotechnology (Group) has a total shareholder equity of CN¥4.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.1B and CN¥960.8M respectively. Anhui Anke Biotechnology (Group)'s EBIT is CN¥941.9M making its interest coverage ratio -220.1. It has cash and short-term investments of CN¥1.6B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -220.1x |
| Cash | CN¥1.58b |
| Equity | CN¥4.17b |
| Total liabilities | CN¥960.81m |
| Total assets | CN¥5.13b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300009's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥793.0M).
Long Term Liabilities: 300009's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥167.8M).
Debt to Equity History and Analysis
Debt Level: 300009 is debt free.
Reducing Debt: 300009 has no debt compared to 5 years ago when its debt to equity ratio was 3.3%.
Debt Coverage: 300009 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300009 has no debt, therefore coverage of interest payments is not a concern.